Privia Health Group, Inc. (PRVA) stock

PRVANasdaqServices-Health ServicesFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/3060% above fair value

$24.55+0.88 (+3.72%)

Close on Nov 13, 2026Market cap $3.14BP/E 94.4Yield –

Privia Health r&d expenses

Research and development expenses are spending on new products and technology.

Privia Health has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Parsed from the XBRL in Privia Health's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is PRVA.

Revenue growth19.2% · median 15.9%

Operating margin2.1% · median 0.3%

Net margin1.4% · median -0.3%

Advertisement
300 × 250

See a number that looks wrong?